% Expired Patents = 85.7

EPO Patents = 1

Trademarks = 49

Forward Citations = 2

Loading Chart...

1 inventor (with patents filed for the assignee):

Bassam Damaj (7 out of 21 patents)

Servet Buyuktimkin (20 patents)

Nadir Buyuktimkin (20 patents)

4. James L Yeager (23 patents)

5. Albert Liu (2 patents)

7 patents: Sort by Forward Citations

1. 11696899 - Oral compositions comprising cinnamaldehyde and uses thereof (2023-07-11),

2. 11110101 - Prostate function support formula (2021-09-07),

3. 11000527 - Therapeutic methods and compositions (2021-05-11),

4. 10864205 - Nutritional supplement for improving sexual health in men and women (2020-12-15),

5. 10758505 - Therapeutic compositions and methods (2020-09-01),

6. 10500199 - Nutritional supplement for increasing cognitive functions (2019-12-10),

7. 10456401 - Therapeutic methods and compositions (2019-10-29),

Company Overview

Innovus Pharmaceuticals, Inc. is a specialty pharmaceutical company that commercializes over-the-counter and consumer products for men's and women's health. With a focus on innovative solutions for sexual health, vitality, and respiratory health, Innovus aims to improve the quality of life for consumers worldwide. The company is committed to delivering high-quality products through research, development, and strategic partnerships.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

7 Patents

#702 in San Diego, CA

#9,491 in California

#39,879 in US

San Diego, CA, United States of America

Innovus Pharmaceuticals, Inc.

Forward Citations = 2

1 inventor:

Bassam Damaj (7 out of 21 patents)

Servet Buyuktimkin (20 patents)

Nadir Buyuktimkin (20 patents)

4. James L Yeager (23 patents)

5. Albert Liu (2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Innovus Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/innovus-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]